Relationship between IL-10 gene -1082A/G and -592C/A polymorphisms and the risk of hepatitis C infection: A meta-analysis

Journal of Viral Hepatitis

Volumn 20, Issue 9, 2013, Pages 602-611

  Sun, X R ^a   Wu, J ^a   Shi, K Q ^a,b   Tang, K F ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

chronic hepatitis C; IL 10 gene; meta analysis; polymorphism

Indexed keywords

INTERLEUKIN 10;

ARTICLE; ASIAN; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; ETHNICITY; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HEREDITY; HUMAN; IMMUNOREGULATION; INFECTION SENSITIVITY; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

CHRONIC HEPATITIS C; IL-10 GENE; META-ANALYSIS; POLYMORPHISM;

DISEASE RESISTANCE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS C; HUMANS; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT;

EID: 84881480643     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12082     Document Type: Article

References (49)

1. Baldo V, Baldovin T, Trivello R, Floreani A,. Epidemiology of HCV infection. Curr Pharm Des 2008; 14 (17): 1646-1654.
2. Rehermann B, Nascimbeni M,. Immunology of hepatitis b virus and hepatitis c virus infection. Nat Rev Immu 2005; 5 (3): 215-229.
3. Thomas DJ, Astemborski J, Rai RM, et al,. The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA 2000; 284 (4): 450-456.
4. Ramos JA, Silva R, Hoffmann L, et al,. Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro. BMC Res Notes 2012; 5 (1): 508.
5. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A,. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
6. Tsukamoto H,. Is interleukin-10 anti-fibrogenic in chronic liver injury? Hepatology 1998; 28 (6): 1707-1709.
7. Del Prete G, Maggi E, Romagnani S,. Human Th1 and Th2 cells: functional properties, mechanisms of regulation and the role in disease. Lab Invest 1994; 70 (3): 229-306.
8. Peters M,. Actions of cytokines on the immune response and viral interactions: an overview. Hepatology 1996; 23 (4): 909-916.
9. Prezzi C, Casc-iaro MA, Francavilla V, Schiafella E, Finocchi L, Chircu LV,. Virus specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol 2001; 31 (3): 894-906.
10. Koziel MJ,. Cytokines in viral hepatitis. Semin Liver Dis 1999; 19 (2): 157-169.
11. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV,. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24 (1): 1-8.
12. Yilmaz V, Yentur SP, Saruhan-Direskeneli G,. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30 (4): 188-194.
13. Paladino N, Fainboim H, Theiler G, et al,. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin-10 promoter polymorphism. J Virol 2006; 80 (18): 9144-9150.
14. Persico M, Capasso M, Persico E, et al,. Interleukin-10-1082GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 2006; 45 (6): 779-785.
15. Vidigal PG, Germer JJ, Zein NN,. Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol 2002; 36 (2): 271-277.
16. Afzal MS, Tahir S, Salman A, et al,. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries 2011; 5 (6): 473-479.
17. Mao XW, Yue W,. Interleukin-10 gene polymorphisms with hepatitis C virus infection, illness and prognosis study. Clin Med China (Chin) 2006; 22: 1091-1093.
18. Chen TY, Hsech YS, Wu TT, et al,. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res 2007; 150 (2): 116-121.
19. Chuang JY, Yang SS, Lu YT, et al,. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Dig Liver Dis 2009; 41 (6): 424-430.
20. Gao QJ, Liu DW, Zhang SY, et al,. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 2009; 15 (44): 5610-5619.
21. Gao Q, Zhang S, Wu L, Jia M, Mi Y, Liu D,. Association of IL-10-1082 and IL-10-592 polymorphisms with chronic hepatitis B and/or hepatitis C virus infection among plasma donors in a rural area of Hebei Province, China. Wei Sheng Yan Jiu 2011; 40 (6): 709-713.
22. Rao HY, Wei L,. Introduction and comments on EASL clinical practice guidelines: management of hepatitis C virus infection. Zhonghua Gan Zang Bing Za Zhi 2011; 19 (5): 391-394.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560.
24. Tobias A,. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 8: 15-17.
25. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629-634.
26. Lio D, Caruso C, Di Stefano R, et al,. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol 2003; 64 (7): 674-680.
27. Naslednikova IO, Konenkov VI, Ryazantseva NV, et al,. Role of genetically determined production of immunoregulatory cytokines in immunopathogenesis of chronic viral hepatitides. Bull Exp Biol Med 2007; 143 (6): 706-712.
28. Zhang LZ, Zhang TC, Pan FM, Zhang ZH, Li X,. Interleukin-10 gene polymorphisms in association with susceptibility to chronic hepatitis C virus infection: a meta-analysis study. Arch Virol 2010; 155 (11): 1839-1842.
29. Meenagh A, Williams F, Ross OA, et al,. Frequency of cytokine polymorphisms in population from Western Europe, Africa, Asia, Middle East and South America. Hum Immunol 2002; 63 (11): 1055-1061.
30. Abayli B, Canataroglu A, Akkiz H,. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection. Turk J Gastroenterol 2003; 14 (1): 7-11.
31. Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, Yoshioka K,. Production of interleukins 10 and 12 by peripheral blond mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1997; 108 (1): 138-143.
32. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE,. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon-alfa. Hepatology 1999; 30 (2): 526-530.
33. Li J, Liu Y, Xu F, Chen J, Chen Y,. Three polymorphisms in the IL-10 gene and the risk of HCV infection: a meta-analysis plus a Chinese Association Study involving 1140 subjects. Epidemiol Infect 2012; 27: 1-12.
34. Knapp S, Hennig BJ, Frodsham AJ, et al,. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 2003; 55 (6): 362-369.
35. Steinke JW, Berekzi E, Hagman J, Boriah L,. Functional analysis of -571 IL-10 promoter polymorphism reveals a suppressor element controlled by sp1. J Immunol 2004; 173 (5): 3215-3222.
36. Clerici M, Wynn TA, Berzofsky JA, et al,. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93 (2): 768-775.
37. Tang JL,. Selection bias in meta-analyses of gene-disease associations. PLoS Med 2005; 2 (12): e409.
38. Shaker OG, Sadik NA,. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy. J Gastroenterol Hepatol 2012; 27 (12): 1842-1849.
39. Zhang XL, Zhao WH,. Cytokines Gene Polymorphisms and Hepatitis C Virus Infection in Chinese Hemodialysis Patients. Thesis: Nanjing Medical University: China, 2011.
40. Dogra G, Chakravarti A, Kar P, Chawla YK,. Polymorphism of tumor necrosis factor-alpha and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated Interferon-a therapy response. Hum Immunol 2011; 72 (10): 935-939.
41. Abbas OM, Abdel-Rahman MH, Omar NA, Badran HM, Amir EM,. Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection. Liver International 2009; 29 (9): 1422-1430.
42. Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, Reis MG,. Association of TGF-beta 1 Codon 25(G915C) Polymorphism with hepatitis C virus infection. J Med Virol 2008; 80 (1): 58-64.
43. Kusumoto K, Uto H, Hayashi K, et al,. Interleukin-10 or tumor necrosis factor-α polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 2006; 34 (1-2): 24-31.
44. Minton EJ, Smillie D, Smith P, et al,. Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes. Hum Immunol 2005; 66 (2): 127-132.
45. Zeng JT, Liu ZW, Han QY, Zhang N,. Genetic polymorphisms of interleukin-10 promoter region in patients with chronic HCV infection. J Xi'an Jiaotong Univ 2005; 26 (1): 37-39.
46. Zein NN, Germer JJ, El-Zayadi AR, Vidigal PG,. Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in patients with chronic hepatitis C virus infection. Am J Trop Med Hyg 2004; 70 (4): 434-437.
47. Mangia A, Santoro R, Piattelli M, et al,. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 2004; 25 (3): 103-109.
48. Bouzgarrou N, Hassen E, Farhat K, et al,. Combined analysis of interferon-γ and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol 2009; 70 (4): 230-236.
49. Abe H, Aizawa Y, Takahashi H, Amano K, Zeniy M,. Single nucleotide polymorphisms in the interleukin-10 gene promoter and clinical outcome of chronic hepatitis C virus infection. Jikeikai Med J 2003; 50 (4): 159-166.